An act to amend 2019 PA 39, entitled “An act to allow certain employees or agents to carry and administer opioid antagonists in certain circumstances; to provide access to opioid antagonists by certain agencies and employees or agents; to limit the civil and criminal liability of certain agencies and employees or agents for the possession, distribution, and use of opioid antagonists under certain circumstances; and to repeal acts and parts of acts,” by amending the title and sections 103 and 107 (MCL 15.673 and 15.677), section 107 as amended by 2020 PA 321, and by adding section 106.
House Bill 5077 would amend the Administration of Opioid Antagonists Act to specify that an agency that purchased or otherwise obtained and possessed an opioid antagonist or an employee or agency of an agency who possessed an opioid antagonist distributed to that employee or agency could distribute that opioid antagonist directly or indirectly to any individual.
Co-sponsored by Reps.
Referred to the Committee on Health Policy
Reported without amendment
Passed in the House 96 to 11 (details)
Motion to give immediate effect
by
The motion prevailed by voice vote
Referred to the Committee on Health Policy
Reported without amendment
Referred to the Committee of the Whole
Reported without amendment
Passed in the Senate 37 to 0 (details)
